Literature DB >> 28541295

Spondyloarthropathies: Abatacept treatment for PsA.

Dario Ummarino.   

Abstract

Entities:  

Year:  2017        PMID： 28541295     DOI： 10.1038/nrrheum.2017.84

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis.

Authors:  Philip J Mease; Alice B Gottlieb; Désirée van der Heijde; Oliver FitzGerald; Alyssa Johnsen; Marleen Nys; Subhashis Banerjee; Dafna D Gladman
Journal:  Ann Rheum Dis       Date:  2017-05-04       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.